Inventor · disambiguated record
Harald-Gerhard Geppert
Also filed as: GEPPERT HARALD-GERHARD
10 granted patents·3 pending applications·107 citations·filing 2005–2023
90Inventor score
Files withGANYMED PHARMACEUTICALS AG5ASTELLAS PHARMA INC3SAHIN UGUR3GANYMED PHARMACEUTICALS GMBH1Türeci Özlem1
Top patents by PatentIndex Score
13 records- 0195US8168427B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2006·Granted May 1, 2012·47 cites·5 claims
- 0294US9751934B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Sep 5, 2017·13 cites·20 claims
- 0390US9044382B2Genetic products differentially expressed in tumors and the use thereofTüreci Özlem·Filed 2005·Granted Jun 2, 2015·17 cites·7 claims
- 0489US10017564B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS GMBH·Filed 2016·Granted Jul 10, 2018·6 cites·21 claims
- 0589US9212228B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2012·Granted Dec 15, 2015·9 cites·42 claims
- 0688US2024117022A1Monoclonal antibodies against claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0787US10738108B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2017·Granted Aug 11, 2020·2 cites·28 claims
- 0885US10174104B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Jan 8, 2019·3 cites·24 claims
- 0985US9775785B2Antibody to genetic products differentially expressed in tumors and the use thereofGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Oct 3, 2017·5 cites·12 claims
- 1085US9499609B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2011·Granted Nov 22, 2016·5 cites·21 claims
- 1175US11739139B2Monoclonal antibodies against Claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2020·Granted Aug 29, 2023·0 cites·18 claims
- 1273US2021145700A1Genetic products differentially expressed in tumors and the use thereofASTELLAS PHARMA INC·Filed 2020·Application pending·0 cites
- 1357US2017240646A1Genetic products differentially expressed in tumors and the use thereofGANYMED PHARMACEUTICALS AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harald-Gerhard Geppert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →